BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19743892)

  • 1. Foamy virus vectors for gene transfer.
    Trobridge GD
    Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large animal models for foamy virus vector gene therapy.
    Trobridge GD; Horn PA; Beard BC; Kiem HP
    Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs.
    Simantirakis E; Tsironis I; Vassilopoulos G
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32204324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Vivo Gene Therapy with Foamy Virus Vectors.
    Rajawat YS; Humbert O; Kiem HP
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
    Everson EM; Hocum JD; Trobridge GD
    J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foamy-virus-mediated gene transfer to canine repopulating cells.
    Kiem HP; Allen J; Trobridge G; Olson E; Keyser K; Peterson L; Russell DW
    Blood; 2007 Jan; 109(1):65-70. PubMed ID: 16968897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells.
    Zhang Y; Liu Y; Zhu G; Qiu Y; Peng B; Yin J; Liu W; He X
    J Neurovirol; 2010 Nov; 16(6):419-26. PubMed ID: 20969536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
    Trobridge GD; Beard BC; Wu RA; Ironside C; Malik P; Kiem HP
    PLoS One; 2012; 7(9):e45173. PubMed ID: 23028826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
    Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
    Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the in vivo safety of insulated foamy viral vectors.
    Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
    Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.
    Ho YP; Schnabel V; Swiersy A; Stirnnagel K; Lindemann D
    Mol Ther; 2012 Jun; 20(6):1167-76. PubMed ID: 22472951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
    Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
    Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
    Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
    Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.
    Trobridge G; Russell DW
    J Virol; 2004 Mar; 78(5):2327-35. PubMed ID: 14963129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foamy virus vector integration sites in normal human cells.
    Trobridge GD; Miller DG; Jacobs MA; Allen JM; Kiem HP; Kaul R; Russell DW
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1498-503. PubMed ID: 16428288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of foamy virus vector and transduction of hematopoietic cells.
    Josephson NC; Russell DW
    Cold Spring Harb Protoc; 2010 Sep; 2010(9):pdb.prot5481. PubMed ID: 20810629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
    Rethwilm A
    Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foamy virus biology and its application for vector development.
    Lindemann D; Rethwilm A
    Viruses; 2011 May; 3(5):561-85. PubMed ID: 21994746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulated Foamy Viral Vectors.
    Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
    Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.